Exclusive: This All-Digital Technology Could Help Fight a Common Liver Disease

Beginning of dialog window. Escape will cancel and close the window. Virta Health, a digital health upstart that helps treat and prevent diabetes without the use of medication or surgery, is touting a new study showing the approach also holds promise for a common liver disease, Fortune has learned. “These study results are particularly exciting because there are currently no drugs on the market to treat the condition,” Virta CEO Sami Inkinen told Fortune in an interview. The condition is called nonalcoholic fatty liver disease (NAFLD) and involves a buildup of fatty tissue in the liver. Appproximately 30% to 40% of American adults have NAFLD, according to the National Institutes for Health (NIH) – a figure likely informed by the fact that people with obesity or type 2 diabetes are at significantly higher risk for the disorder. Read more here >>>

thumbnail courtesy of fortune.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here